Jerzy Supronik

Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study

Mark C. Genovese, Patrick Durez, Hanno B. Richards et al. · Annals of the Rheumatic Diseases · 2012 · 286 citations

Effects of Intravenous Zoledronic Acid Once Yearly on Bone Remodeling and Bone Structure

Robert R. Recker, Pierre D. Delmas, Johan Halse et al. · Journal of Bone and Mineral Research · 2007 · 223 citations

Low-dose prednisone chronotherapy for rheumatoid arthritis: a randomised clinical trial (CAPRA-2)

Frank Buttgereit, Daksha Mehta, John Kirwan et al. · Annals of the Rheumatic Diseases · 2013 · 185 citations · Full text

Efficacy and Safety of Secukinumab 150 mg with and Without Loading Regimen in Ankylosing Spondylitis: 104-week Results from MEASURE 4 Study

Alan Kivitz, Ulf Wagner, Eva Dokoupilová et al. · Rheumatology and Therapy · 2018 · 117 citations · Full text

One-year Efficacy and Safety Results of Secukinumab in Patients With Rheumatoid Arthritis: Phase II, Dose-finding, Double-blind, Randomized, Placebo-controlled Study

Mark C. Genovese, Patrick Durez, Hanno B. Richards et al. · The Journal of Rheumatology · 2014 · 97 citations · Full text